← All trials
NCT03723837
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 15, 2018
- Primary completion
- Jul 15, 2019
- Completion date
- Aug 15, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 500
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tribhuvan UniversityLead sponsor
- Tribhuvan UniversityOverall official - principal investigator
- Tribhuvan UniversityReponsible party - principal investigator
- Centers for Disease Control and Prevention (CDC)Collaborator
- Centers for Disease Control and Prevention (CDC)Overall official - principal investigator
- World Health OrganizationCollaborator
- World Health OrganizationOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.